These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37141698)

  • 21. RN181 regulates the biological behaviors of oral squamous cell carcinoma cells via mediating ERK/MAPK signaling pathway.
    Li Y; Xiang ZY; Xiong J; Hou ZW; Zhu Z; Bao WW
    Acta Histochem; 2021 Jul; 123(5):151733. PubMed ID: 34052676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).
    Dong Y; Xue L; Zhang Y; Liu C; Zhang Y; Jiang N; Ma X; Chen F; Li L; Yu L; Liu X; Shao S; Guan S; Zhang J; Xiao Q; Li H; Dong A; Huang L; Shi C; Wang Y; Fu M; Lv N; Zhan Q
    J Exp Clin Cancer Res; 2022 Apr; 41(1):150. PubMed ID: 35449073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophils regulate tumor angiogenesis in oral squamous cell carcinoma and the role of Chemerin.
    Gao F; Feng Y; Hu X; Zhang X; Li T; Wang Y; Ge S; Wang C; Chi J; Tan X; Wang N
    Int Immunopharmacol; 2023 Aug; 121():110540. PubMed ID: 37354780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
    Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
    Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process].
    Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway.
    Liu H; Zhang H; Fan H; Tang S; Weng J
    Dis Markers; 2022; 2022():1217918. PubMed ID: 35978886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA BANCR promotes proliferation and migration in oral squamous cell carcinoma via MAPK signaling pathway.
    Yao C; Kong F; Zhang S; Wang G; She P; Zhang Q
    J Oral Pathol Med; 2021 Mar; 50(3):308-315. PubMed ID: 31654433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic restraint stress promotes the tumorigenic potential of oral squamous cell carcinoma cells by reprogramming fatty acid metabolism via CXCL3 mediated Wnt/β-catenin pathway.
    Lou F; Long H; Luo S; Liu Y; Pu J; Wang H; Ji P; Jin X
    Exp Neurol; 2023 Jan; 359():114268. PubMed ID: 36343679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
    Mohan S; Vander Broek R; Shah S; Eytan DF; Pierce ML; Carlson SG; Coupar JF; Zhang J; Cheng H; Chen Z; Van Waes C
    Clin Cancer Res; 2015 Sep; 21(17):3946-56. PubMed ID: 25977343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific Deletion of p16
    Ishida K; Tomita H; Kanayama T; Noguchi K; Niwa A; Kawaguchi M; Miyai M; Matsuo M; Imaizumi Y; Kato K; Hatano Y; Hirata A; Okada H; Shibata T; Hara A
    Am J Pathol; 2020 Jun; 190(6):1332-1342. PubMed ID: 32194051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
    Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
    Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways.
    Granda-Díaz R; Manterola L; Hermida-Prado F; Rodríguez R; Santos L; García-de-la-Fuente V; Fernández MT; Corte-Torres MD; Rodrigo JP; Álvarez-Teijeiro S; Lawrie CH; Garcia-Pedrero JM
    Biomed Pharmacother; 2023 May; 161():114512. PubMed ID: 36931033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. San-Zhong-Kui-Jian-Tang Exerts Antitumor Effects Associated With Decreased Cell Proliferation and Metastasis by Targeting ERK and the Epithelial-Mesenchymal Transition Pathway in Oral Cavity Squamous Cell Carcinoma.
    Hsu PY; Chen JL; Kuo SL; Wang WL; Jan FW; Yang SH; Yang CY
    Integr Cancer Ther; 2022; 21():15347354221134921. PubMed ID: 36404765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DDX27 regulates oral squamous cell carcinoma development through targeting CSE1L.
    Li G; Li R; Wang W; Sun M; Wang X
    Life Sci; 2024 Mar; 340():122479. PubMed ID: 38301874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
    J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z; Hao XY; Liu FX
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Porphyromonas gingivalis Activation of Tumor-Associated Macrophages via DOK3 Promotes Recurrence of Oral Squamous Cell Carcinoma.
    Li CX; Su Y; Gong ZC; Liu H
    Med Sci Monit; 2022 Oct; 28():e937126. PubMed ID: 36210538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
    He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
    Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CircLPAR3 Acts as an Oncogene in Oral Squamous Cell Carcinoma Through Regulating the miR-643/HMGB2 Network.
    Fu Y; Qiu C; Yang Y; Lu J; Qi Y
    Biochem Genet; 2022 Jun; 60(3):882-898. PubMed ID: 34528144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.